MONDO_0009575 (thiamine-responsive megaloblastic anemia syndrome) can be described as follows. Thiamine-responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type I diabetes mellitus, and sensorineural deafness. Also known as: Rogers syndrome, THMD1, TRMA, thiamine metabolism dysfunction syndrome 1, thiamine-responsive anaemia syndrome, thiamine-responsive anemia syndrome, thiamine-responsive megaloblastic anaemia with diabetes mellitus and sensorineural deafness, thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness.